Amgen (AMGN) FY2021 results: revenue $26.0 billion, up 2.2% on the year
Amgen Inc. (AMGN) reported revenue of $26.0 billion for fiscal 2021, the year ended 31 December 2021, up 2.2% on the year before. Net income was $5.9 billion, down 18.9%, and diluted earnings per share $10.28. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2022.
Revenue
$26.0 billion
+2.2% on the year
FY2014FY2021
Operating margin
29.4%
35.9% a year earlier
FY2014FY2021
Net income
$5.9 billion
-18.9% on the year
FY2014FY2021
Diluted EPS
$10.28
-16.5% on the year
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
9,261
10,497
9,150
-11.8%
Capital expenditure
880
608
618
+44.7%
Free cash flow
8,381
9,889
8,532
-15.2%
Free cash flow margin
32.3%
38.9%
36.5%
Cash from investing
733
-5,401
5,709
Cash from financing
-8,271
-4,867
-15,767
Depreciation and amortisation
3,398
3,601
2,206
-5.6%
Share-based compensation
341
330
308
+3.3%
Buybacks
4,975
3,486
7,702
+42.7%
Dividends paid
4,013
3,755
3,509
+6.9%
Dividend per share
$7.22
$6.56
$5.95
+10.1%
Diluted shares, weighted
573m
590m
609m
-2.9%
Shares outstanding at period end
558m
578m
591m
-3.5%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
6,700
9,409
9,673
-28.8%
Debt
33,309
32,986
29,903
+1.0%
Operating lease liabilities
525
306
388
+71.6%
Other liabilities
20,631
20,247
19,743
+1.9%
Total liabilities and equity
61,165
62,948
59,707
-2.8%
Fixed assets
5,184
4,889
4,928
+6.0%
Goodwill
14,890
14,689
14,703
+1.4%
Intangible assets
15,182
16,587
19,413
-8.5%
Investments
48.0
4,381
2,874
-98.9%
Cash and equivalents
7,989
6,266
6,037
+27.5%
Receivables
4,895
4,525
4,057
+8.2%
Inventory
4,086
3,893
3,584
+5.0%
Other assets
8,891
7,718
4,111
+15.2%
Total assets
61,165
62,948
59,707
-2.8%
10-K for the year ended 31 December 2021, filed 16 February 2022: the filing.